145 related articles for article (PubMed ID: 25411791)
21. Mesangiocapillary glomerulonephritis in Down's syndrome.
Gupta SK; Venkataseshan VS; Churg J
Am J Nephrol; 1991; 11(2):112-7. PubMed ID: 1835296
[TBL] [Abstract][Full Text] [Related]
22. Quantitative analysis of the interstitial myofibroblasts in idiopathic mesangiocapillary glomerulonephritis type I.
Danilewicz M; Antoszczyk L; Wagrowska-Danilewicz M
Pathol Res Pract; 1999; 195(10):663-8. PubMed ID: 10549029
[TBL] [Abstract][Full Text] [Related]
23. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
24. Structural-functional relationships in type I mesangiocapillary glomerulonephritis.
Hattori M; Kim Y; Steffes MW; Mauer SM
Kidney Int; 1993 Feb; 43(2):381-6. PubMed ID: 8441233
[TBL] [Abstract][Full Text] [Related]
25. [Mesangiocapillary glomerulonephritis].
Pál K; Nagy J
Orv Hetil; 1996 Jun; 137(26):1403-7. PubMed ID: 9182265
[TBL] [Abstract][Full Text] [Related]
26. The pathogenesis of membranoproliferative glomerulonephritis in KwaZulu-Natal, South Africa is unrelated to hepatitis C virus infection.
Madala ND; Naicker S; Singh B; Naidoo M; Smith AN; Rughubar K
Clin Nephrol; 2003 Aug; 60(2):69-73. PubMed ID: 12940606
[TBL] [Abstract][Full Text] [Related]
27. In search of an effective treatment for recurrent mesangiocapillary glomerulonephritis in the renal allograft.
Cai MM; Simpson I; Mulley WR
Nephrology (Carlton); 2014 Apr; 19 Suppl 1():6-9. PubMed ID: 24460538
[TBL] [Abstract][Full Text] [Related]
28. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
29. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome.
Chen A; Frank R; Vento S; Crosby V; Chandra M; Gauthier B; Valderrama E; Trachtman H
BMC Nephrol; 2007 Aug; 8():11. PubMed ID: 17683621
[TBL] [Abstract][Full Text] [Related]
30. Membranous nephropathy with crescents: a series of 19 cases.
Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
[TBL] [Abstract][Full Text] [Related]
31. Mesangiocapillary glomerulonephritis type III and idiopathic membranous glomerulopathy. Morphometric comparison of the deposits and glomerular basement membrane including clinico-morphological correlations.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 1997; 48(1):43-8. PubMed ID: 9200960
[TBL] [Abstract][Full Text] [Related]
32. Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients.
Nasr SH; Valeri AM; Appel GB; Sherwinter J; Stokes MB; Said SM; Markowitz GS; D'Agati VD
Clin J Am Soc Nephrol; 2009 Jan; 4(1):22-32. PubMed ID: 18971369
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis.
Kapitsinou PP; Ioannidis JP; Boletis JN; Sotsiou F; Nakopoulou L; Daphnis E; Moutsopoulos HM
Am J Kidney Dis; 2003 Jan; 41(1):29-37. PubMed ID: 12500219
[TBL] [Abstract][Full Text] [Related]
35. Renal outcome and risk factors for end-stage renal disease in pediatric rapidly progressive glomerulonephritis.
Piyaphanee N; Ananboontarick C; Supavekin S; Sumboonnanonda A
Pediatr Int; 2017 Mar; 59(3):334-341. PubMed ID: 27542664
[TBL] [Abstract][Full Text] [Related]
36. Nephrotic syndrome in adult black South Africans: HIV-associated nephropathy as the main culprit.
Okpechi IG; Rayner BL; Swanepoel CR
J Natl Med Assoc; 2010 Dec; 102(12):1193-7. PubMed ID: 21287900
[TBL] [Abstract][Full Text] [Related]
37. Hypertension in pregnancy: A future risk for chronic kidney disease in South Africa.
Jones E; Rayner BL
S Afr Med J; 2019 Aug; 109(9):665-667. PubMed ID: 31635591
[TBL] [Abstract][Full Text] [Related]
38. [Risk factors affecting the long-term outcome of IgA nephropathy].
Yang NS; Wu QQ; Du Y; Zhang R; Li YJ; Ye RG; Yu XQ
Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):597-600. PubMed ID: 16194415
[TBL] [Abstract][Full Text] [Related]
39. Primary FSGS in Nephrotic Adults: Clinical Profile, Response to Immunosuppression and Outcome.
Bagchi S; Agarwal S; Kalaivani M; Bhowmik D; Singh G; Mahajan S; Dinda A
Nephron; 2016; 132(2):81-5. PubMed ID: 26799973
[TBL] [Abstract][Full Text] [Related]
40. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
